148 related articles for article (PubMed ID: 38497483)
21. Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
Chen KH; Dasgupta A; Lin J; Potus F; Bonnet S; Iremonger J; Fu J; Mewburn J; Wu D; Dunham-Snary K; Theilmann AL; Jing ZC; Hindmarch C; Ormiston ML; Lawrie A; Archer SL
Circulation; 2018 Jul; 138(3):287-304. PubMed ID: 29431643
[TBL] [Abstract][Full Text] [Related]
22. Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1/PPAR-γaxis.
Zhang S; Liu J; Zheng K; Chen L; Sun Y; Yao Z; Sun Y; Lin Y; Lin K; Yuan L
Vascul Pharmacol; 2021 Feb; 136():106820. PubMed ID: 33238205
[TBL] [Abstract][Full Text] [Related]
23. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.
Brock M; Schuoler C; Leuenberger C; Bühlmann C; Haider TJ; Vogel J; Ulrich S; Gassmann M; Kohler M; Huber LC
Exp Biol Med (Maywood); 2017 Mar; 242(5):487-496. PubMed ID: 28056547
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension.
Liu H; Yin T; Yan W; Si R; Wang B; Chen M; Li F; Wang Q; Tao L
Int J Chron Obstruct Pulmon Dis; 2017; 12():1781-1791. PubMed ID: 28684904
[TBL] [Abstract][Full Text] [Related]
25. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension.
Li Y; Ren W; Wang X; Yu X; Cui L; Li X; Zhang X; Shi B
Biomed Pharmacother; 2019 Jan; 109():1740-1749. PubMed ID: 30551428
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension.
Pullamsetti SS; Doebele C; Fischer A; Savai R; Kojonazarov B; Dahal BK; Ghofrani HA; Weissmann N; Grimminger F; Bonauer A; Seeger W; Zeiher AM; Dimmeler S; Schermuly RT
Am J Respir Crit Care Med; 2012 Feb; 185(4):409-19. PubMed ID: 22161164
[TBL] [Abstract][Full Text] [Related]
28. Targeting Endothelial ENO1 (Alpha-Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension.
Shi Y; Liu J; Zhang R; Zhang M; Cui H; Wang L; Cui Y; Wang W; Sun Y; Wang C
Hypertension; 2023 May; 80(5):1035-1047. PubMed ID: 37075135
[TBL] [Abstract][Full Text] [Related]
29. circ_0023461 Silencing Protects Cardiomyocytes from Hypoxia-Induced Dysfunction through Targeting miR-370-3p/PDE4D Signaling.
Ren K; Li B; Jiang L; Liu Z; Wu F; Zhang Y; Liu J; Duan W
Oxid Med Cell Longev; 2021; 2021():8379962. PubMed ID: 34630853
[TBL] [Abstract][Full Text] [Related]
30. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
31. Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages.
Hu L; Yu Y; Shen Y; Huang H; Lin D; Wang K; Yu Y; Li K; Cao Y; Wang Q; Sun X; Qiu Z; Wei D; Shen B; Chen J; Fulton D; Ji Y; Wang J; Chen F
Redox Biol; 2023 May; 61():102638. PubMed ID: 36801705
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.
Baptista R; Marques C; Catarino S; Enguita FJ; Costa MC; Matafome P; Zuzarte M; Castro G; Reis A; Monteiro P; Pêgo M; Pereira P; Girão H
Cardiovasc Res; 2018 Jan; 114(1):53-64. PubMed ID: 29016730
[TBL] [Abstract][Full Text] [Related]
33. PVECs-Derived Exosomal microRNAs Regulate PASMCs via FoxM1 Signaling in IUGR-induced Pulmonary Hypertension.
Luo X; Hang C; Zhang Z; Le K; Ying Y; Lv Y; Yan L; Huang Y; Ye L; Xu X; Zhong Y; Du L
J Am Heart Assoc; 2022 Dec; 11(24):e027177. PubMed ID: 36533591
[TBL] [Abstract][Full Text] [Related]
34. SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
Veith C; Vartürk-Özcan I; Wujak M; Hadzic S; Wu CY; Knoepp F; Kraut S; Petrovic A; Gredic M; Pak O; Brosien M; Heimbrodt M; Wilhelm J; Weisel FC; Malkmus K; Schäfer K; Gall H; Tello K; Kosanovic D; Sydykov A; Sarybaev A; Günther A; Brandes RP; Seeger W; Grimminger F; Ghofrani HA; Schermuly RT; Kwapiszewska G; Sommer N; Weissmann N
Circulation; 2022 Mar; 145(12):916-933. PubMed ID: 35175782
[TBL] [Abstract][Full Text] [Related]
35. Overexpressed pigment epithelium-derived factor alleviates pulmonary hypertension in two rat models induced by monocrotaline and SU5416/hypoxia.
Miao H; Hui H; Fan W; Lin Y; Li H; Li D; Luo M; Qiu F; Jiang B; Zhang Y
Biomed Pharmacother; 2024 Mar; 172():116303. PubMed ID: 38377738
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia is involved in hypoxic pulmonary hypertension through inhibiting the activation of FGF2 by miR-203.
Wang LN; Yu WC; Du CH; Tong L; Cheng ZZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8866-8876. PubMed ID: 30575929
[TBL] [Abstract][Full Text] [Related]
37. Super Enhancer-Associated Circular RNA-CircKrt4 Regulates Hypoxic Pulmonary Artery Endothelial Cell Dysfunction in Mice.
Ma C; Wang X; Zhang L; Zhu X; Bai J; He S; Mei J; Jiang J; Guan X; Zheng X; Qu L; Zhu D
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1179-1198. PubMed ID: 37139839
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA Rps4l Mediates the Proliferation of Hypoxic Pulmonary Artery Smooth Muscle Cells.
Liu Y; Zhang H; Li Y; Yan L; Du W; Wang S; Zheng X; Zhang M; Zhang J; Qi J; Sun H; Zhang L; Li G; Zhu D
Hypertension; 2020 Oct; 76(4):1124-1133. PubMed ID: 32772647
[TBL] [Abstract][Full Text] [Related]
39. Circ_0004104 knockdown alleviates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells through targeting miR-328-3p/TRIM14 axis in atherosclerosis.
Zhang C; Wang L; Shen Y
BMC Cardiovasc Disord; 2021 Apr; 21(1):207. PubMed ID: 33892646
[TBL] [Abstract][Full Text] [Related]
40. The lncRNA PAHRF functions as a competing endogenous RNA to regulate MST1 expression by sponging miR-23a-3p in pulmonary arterial hypertension.
Liu Y; Hu R; Zhu J; Nie X; Jiang Y; Hu P; Liu Y; Sun Z
Vascul Pharmacol; 2021 Aug; 139():106886. PubMed ID: 34126237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
